-+ 0.00%
-+ 0.00%
-+ 0.00%
Evotec Lands $2.9M Gates Foundation Grant Giving Global Health Researchers Continued Access To Stem Cell Platform For Early Drug Safety Assessment
Share
Listen to the news
  • New three-year grant from the Gates Foundation extends a 2023 project to help global health researchers predict potential fetal development risks posed by novel drug candidates
  • Evotec's human stem cell-based platform enables better-informed decisions regarding which drug candidates to advance into clinical testing
  • Continued collaboration underscores Evotec's capabilities in advanced human cell-based drug discovery technologies
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending